Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dopamine D1 receptor (D1R) is a member of the G protein-coupled receptor (GPCR) family, specifically classified within the D1-like subfamily. It is the most abundant dopamine receptor subtype in the central nervous system and plays a key role in regulating motor behavior, reward processing, motivation, memory formation, learning, attention, impulse control, and neuronal development. Dysfunctional signaling is associated with neuropsychiatric disorders such as Parkinson’s disease (PD), schizophrenia, Huntington's disease, attention deficit hyperactivity disorder (ADHD), cognitive impairment disorders—and plays a role in addiction mechanisms. The D1R is an established therapeutic target for CNS diseases including PD.
Activation stimulates adenylyl cyclase via Gαs/olf coupling, increasing intracellular cAMP levels and activating protein kinase A (PKA).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine D1 Receptor (D1R).